MOH
- Status: likely_approved
🇦🇪 Koselugo in United Arab Emirates
Koselugo (selumetinib) regulatory status in United Arab Emirates.
Marketing authorisations
MOH
- Status: likely_approved
Koselugo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United Arab Emirates
Frequently asked questions
Is Koselugo approved in United Arab Emirates?
Yes. MOH has authorised it; MOH has authorised it.
Who is the marketing authorisation holder for Koselugo in United Arab Emirates?
ASTRAZENECA LP is the originator. The local marketing authorisation holder may differ — check the official source linked above.